|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$1,350
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
5R01CA196266-02
|
$502,591
|
$251,296
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
1R21CA205106-01A1
|
$234,992
|
$234,992
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
|
1R01CA217179-01
|
$566,814
|
$283,407
|
MARKERT, JAMES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
$3,750
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
$1,875
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$234,307
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-04
|
$875,813
|
$875,813
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-11
|
$22,965,613
|
$5,741,403
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$43,778
|
Barr, Frederic
|
CCR (NCI)
|
|
ATM and gammaherpesvirus infection: a precarious balance
|
5R01CA183593-04
|
$317,475
|
$317,475
|
TARAKANOVA, VERA
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$1,183
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$1,189
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$1,223
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$32,531
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-04
|
$688,290
|
$316,613
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$2,199
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$3,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$73,400
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA014236-43S1
|
$116,657
|
$1,167
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S2
|
$29,688
|
$297
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S3
|
$83,246
|
$832
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-43
|
$5,679,062
|
$56,791
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016086-41S1
|
$125,000
|
$8,750
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-41S2
|
$200,180
|
$14,013
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-41S3
|
$126,017
|
$8,821
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016086-41S4
|
$62,502
|
$4,375
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA016086-41
|
$7,114,974
|
$498,048
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
3P30CA016042-42S1
|
$41,000
|
$4,100
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
5P30CA016042-42
|
$4,295,192
|
$429,519
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
3P30CA047904-29S1
|
$115,192
|
$3,456
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-29S2
|
$55,932
|
$1,678
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-29S3
|
$175,000
|
$5,250
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$153,890
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA068485-22S1
|
$118,377
|
$3,551
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-22S2
|
$120,443
|
$3,613
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-22S3
|
$249,999
|
$7,500
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA068485-22S4
|
$25,000
|
$750
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
5P30CA068485-22
|
$5,853,094
|
$175,593
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$1,750
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
5U54CA190155-04
|
$680,763
|
$340,382
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
4R44CA206788-02
|
$939,552
|
$939,552
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Cell model for KSHV infection and genetic manipulation
|
2R01CA096512-10A1
|
$412,500
|
$412,500
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
$9,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$621,630
|
$310,815
|
Yarchoan, Robert
|
CCR (NCI)
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-45
|
$5,113,872
|
$102,277
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-45S1
|
$25,000
|
$500
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Total relevant funding to Herpes - Other for this search: $50,074,340
|